EP02.01. Synergism of KRAS G12C Inhibitor and mTOR Inhibitor in Lung Adenocarcinoma and Squamous Cell Carcinoma - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Masaoki Ito
Meta Tag
Speaker Masaoki Ito
Topic Tumor Biology: Preclinical Biology - Molecular Therapeutic Targets
KRAS G12C inhibitor
mTOR inhibitor
lung adenocarcinoma
squamous cell carcinoma
nucleotide change
smoking-induced variant
Chou-Talalay method
synergistic effect
cell growth suppression
Powered By